Access the “What This Means” segment here CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that it recently participated in a Virtual Investor "What This Means" segment. As part of the segment, Sanjeev Luther, President and CEO of Ernexa, discussed the Company’s recently announced partnership agreement with Cellipont Bioservices focused on ...